Full Press Release Details
Ionis receives FDA Fast Track designation for olezarsen in patients with familial chylomicronemia syndrome.
IONS
Ionis receives FDA Fast Track designation for olezarsen in patients with familial chylomicronemia syndrome
Key Takeaway: Ionis receives FDA Fast Track designation for olezarsen in patients with familial chylomicronemia syndrome